Abstract
Background: Growing cases of ovarian tumor recently documented in worldwide and developing countries like Bangladesh. Objective: In this study our main goal is to evaluate menopausal status score and laboratory profile in all cases of Ovarian Tumor. Method: This cross sectional study was carried out at Department of Obstetrics and Gynaecology, Jalalabad Ragib Rabeya Medical College, Sylhet from January 2019 to December 2019 where a total of 60 women who diagnosed with ovarian tumor were included as a sample size. Results: During the study, mean age was 41.4 (SD±14.7) years and 42 (70.0%) cases were premenopausal and 18 (30.0%) cases were post-menopausal. In addition, of the benign ovarian tumours 29 (76.3%) cases had ultrasonogram score 1 and 9 (23.7%) cases had ultrasonogram score 3; while of the malignant ovarian tumours 3 (13.6%) cases had ultrasonogram score 1 and 19 (66.4%) cases had ultrasonogram score 3. Besides that, Of the benign ovarian tumours 8 (21.1%) cases had serum CA-125 level ≥35U/ml and 30 (78.9%) cases had serum CA-125 level <35U/ml; while of the malignant ovarian tumours 20 (90.9%) cases had serum CA-125 level ≥35U/ml and 2 (9.1%) cases had serum CA-125 level <35U/ml. Besides that, most common benign tumour was mucinous cystadenoma (26.7%) whereas in malignant tumors case seruos cystadenocarcinoma (23.3.0%) were seen commonly. Conclusion: According to our study we can conclude that, premenopausal women were more prone to develop ovarian tumor. Where in benign tumors cases majority were mucinous cystadenoma whereas in malignant tumor cases,serous cystadenocarcinoma was seen commonly. Also, most of the benign tumor had ultrasonogram score 1 where as in malignant cases opposite scenario was seen.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
More From: Scholars International Journal of Obstetrics and Gynecology
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.